The Enterprise Value as of December 2024 (TTM) for Vincerx Pharma, Inc. (VINC) is 4.94M

According to Vincerx Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.94M. This represents a change of -89.69% compared to the average of 47.89M of the last 4 quarters.

Vincerx Pharma, Inc. (VINC) Historical Enterprise Value (quarterly & annually)

How has VINC Enterprise Value performed in the past?

The mean historical Enterprise Value of Vincerx Pharma, Inc. over the last ten years is 74.87M. The current 4.94M Enterprise Value has changed 559.74% with respect to the historical average. Over the past ten years (40 quarters), VINC's Enterprise Value was at its highest in in the March 2021 quarter at 215.10M. The Enterprise Value was at its lowest in in the June 2022 quarter at -49245600.00.

Vincerx Pharma, Inc. (VINC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vincerx Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vincerx Pharma, Inc. (VINC) Average Enterprise Value

How has VINC Enterprise Value performed in the past?

The current Enterprise Value of Vincerx Pharma, Inc. (VINC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vincerx Pharma, Inc. (VINC) Enterprise Value vs. Peers

How is VINC’s Enterprise Value compared to its peers?

Vincerx Pharma, Inc.’s Enterprise Value is greater than Spero Therapeutics, Inc. (-21522160.00), less than Bolt Biotherapeutics, Inc. (28.22M), less than Coherus BioSciences, Inc. (301.50M), less than Gracell Biotechnologies Inc. (5.66B), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Applied Therapeutics, Inc. (3.96M), less than Lyra Therapeutics, Inc. (22.89M), less than Shattuck Labs, Inc. (12.77M), greater than BioAtla, Inc. (-25285893.00), less than Monopar Therapeutics Inc. (122.23M), less than Senti Biosciences, Inc. (43.14M), greater than Processa Pharmaceuticals, Inc. (-108215.00), greater than Fresh Tracks Therapeutics, Inc. (-6447751.00), greater than LAVA Therapeutics N.V. (4.76M), greater than TRACON Pharmaceuticals, Inc. (-6160275.00), less than Rezolute, Inc. (247.72M), less than XOMA Corporation (288.19M), greater than Sio Gene Therapies Inc. (-61213000.00), less than Protara Therapeutics, Inc. (129.56M), greater than Vaccinex, Inc. (338.20K), less than Miromatrix Medical Inc. (90.06M), less than Surrozen, Inc. (9.16M),

Build a custom stock screener for Vincerx Pharma, Inc. (VINC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vincerx Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vincerx Pharma, Inc. (VINC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vincerx Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.